MAGiC Cardiac Ablation Catheter

MAGiC (Magnetic Interventional Ablation Catheter) represents Stereotaxis’ first proprietary ablation catheter, designed specifically for use with the company’s robotic magnetic navigation systems. The FDA approved MAGiC in January 2026 with an indication for treating patients with complex congenital heart disease—the first ablation catheter approved specifically for this underserved patient population.

Product Overview

MAGiC addresses limitations of the legacy third-party catheter (Biosense Webster) that Stereotaxis users had depended on since 2002. The 20-year-old design of the previous catheter left significant room for improvement in clinical performance, stability, and navigation intuitiveness.

Developed following Stereotaxis’ 2024 acquisition of Access Point Technologies, MAGiC incorporates modern catheter engineering optimized specifically for magnetic navigation. The design provides enhanced stability, reduced fluid load, and more intuitive control through the Genesis/GenesisX robotic platforms.

Key Features

MAGiC’s tip-first magnetic navigation enables access to complex congenital anatomy that conventional catheters cannot reach, including the first FDA indication for this patient population.

• Magnetic Navigation Optimized: Designed specifically for RMN systems, not adapted from manual catheters
• Enhanced Stability: Improved tissue contact consistency compared to legacy catheters
• Intuitive Control: More responsive to physician inputs through the Navigant workstation
• Reduced Fluid Load: Lower irrigation requirements during ablation
• Atraumatic Design: Flexible construction minimizes perforation risk
• Complex Anatomy Access: Reaches positions often inaccessible to traditional rigid catheters

Technical Specifications

Approved in January 2026, MAGiC is an irrigated radiofrequency ablation catheter built for Genesis and GenesisX robotic magnetic navigation platforms.

Clinical Applications

Complex Congenital Heart Disease: MAGiC is the first ablation catheter specifically approved for patients with structural cardiac anomalies who typically lack good treatment options. The flexible, magnetically-guided design navigates unusual anatomy that rigid catheters cannot reach.

Atrial Fibrillation: Precise pulmonary vein isolation with consistent tissue contact, supported by the stability advantages of magnetic navigation.

Ventricular Tachycardia: Access to scar-related arrhythmogenic substrates in patients with prior myocardial infarction or cardiomyopathy.

Accessory Pathway Ablation: High-precision targeting of congenital accessory pathways including septal and epicardial locations.

Regulatory Status

MAGiC launched commercially in Europe following CE Mark approval and will begin US commercialization in early 2026.

Clinical Evidence

Initial human procedures with MAGiC were conducted as part of a prospective multicenter clinical study. Results from the first 20 procedures documented:

• 100% acute efficacy
• No adverse events

The company is working with CardioFocus to develop integration with pulsed-field ablation (PFA) technology, potentially combining MAGiC’s navigation advantages with the emerging nonthermal ablation approach.

Strategic Significance

MAGiC represents a critical component of Stereotaxis’ transition to a “razor-and-blades” business model. Rather than depending on third-party catheters, the company now offers a proprietary consumable generating recurring revenue with each procedure. This strategy supports:

• Higher gross margins (70% for recurring revenue vs 20% for systems)
• Reduced dependence on external partners
• Ability to optimize catheter design for RMN-specific advantages
• Faster innovation cycles for new devices

Frequently Asked Questions

What makes MAGiC different from traditional ablation catheters?

MAGiC is navigated from the tip using magnetic fields rather than pushed from the handle. This provides millimeter precision, greater stability, and the ability to reach complex anatomical positions that traditional catheters cannot access.

Who can benefit from MAGiC catheter ablation?

MAGiC is particularly valuable for patients with complex congenital heart disease, complex arrhythmias with unusual anatomy, or those who have failed previous ablation attempts with traditional approaches.

Does MAGiC require special equipment?

Yes, MAGiC requires a Stereotaxis Genesis or GenesisX robotic magnetic navigation system. It cannot be used with manual catheter techniques.